Recondo G.; Bahcall M.; Spurr L.F.; Che J.; Ricciuti B.; Leonardi G.C.; Lo Y.-C.; Li Y.Y.; Lamberti G.; Nguyen T.; Milan M.S.D.; Venkatraman D.; Umeton R.; Paweletz C.P.; Albayrak A.; Cherniack A.D.; Price K.S.; Fairclough S.R.; Nishino M.; Sholl L.M.; Oxnard G.R.; Janne P.A.; Awad M.M., Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 2615 - 2625 [articolo]
Brighi, Nicole; La Rosa, Stefano; Rossi, Giulio; Grillo, Federica; Pusceddu, Sara; Rinzivillo, Maria; Spada, Francesca; Tafuto, Salvatore; Massironi, Sara; Faggiano, Antongiulio; Antonuzzo, Lorenzo; Santini, Donatella; Sessa, Fausto; Maragliano, Roberta; Gelsomino, Fabio; Albertelli, Manuela; Vernieri, Claudio; Panzuto, Francesco; Fazio, Nicola; De Divitiis, Chiara; Lamberti, Giuseppe; Colao, Annamaria; Fave, Gianfranco Delle; Campana, Davide, Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study, «ANNALS OF SURGERY», 2020, 271, pp. 527 - 533 [articolo]
Lamberti G.; Gelsomino F.; Brocchi S.; Poerio A.; Melotti B.; Sperandi F.; Gargiulo M.; Borghi C.; Fiorentino M.; Ardizzoni A., New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, pp. 1 - 6 [articolo]Open Access
Lamberti G.; Faggiano A.; Brighi N.; Tafuto S.; Ibrahim T.; Brizzi M.P.; Pusceddu S.; Albertelli M.; Massironi S.; Panzuto F.; Badalamenti G.; Riccardi F.; Butturini G.; Gelsomino F.; De Divitiis C.; Modica R.; Bongiovanni A.; La Salvia A.; Torchio M.; Colao A.; Ferone D.; Campana D., Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor, «THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM», 2020, 105, pp. 194 - 200 [articolo]
Gelsomino F.; Di Federico A.; Filippini D.M.; Dall'Olio F.G.; Lamberti G.; Sperandi F.; Balacchi C.; Brocchi S.; Ardizzoni A., Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report, «CLINICAL LUNG CANCER», 2020, 21, pp. E45 - E48 [articolo]
Lamberti, Giuseppe; Brizzi, Maria Pia; Pusceddu, Sara; Gelsomino, Fabio; Di Meglio, Giovanni; Massari, Francesco; Badalamenti, Giuseppe; Riccardi, Ferdinando; Ibrahim, Toni; Ciccarese, Chiara; Buti, Sebastiano; Carnaghi, Carlo; Prinzi, Natalie; Panzuto, Francesco; Campana, Davide, Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis, «JOURNAL OF CLINICAL MEDICINE», 2020, 9, Article number: 1351, pp. 1 - 12 [articolo]Open Access
Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A., Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL), «BRITISH JOURNAL OF CANCER», 2020, 123, pp. 26 - 32 [articolo]Open Access
Chiari R.; Ricciuti B.; Landi L.; Morelli A.M.; Delmonte A.; Spitaleri G.; Cortinovis D.L.; Lamberti G.; Facchinetti F.; Pilotto S.; Verusio C.; Chella A.; Bonanno L.; Galetta D.; Cappuzzo F., ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS), «CLINICAL LUNG CANCER», 2020, 21, pp. 15 - 20 [articolo]
Lamberti G.; Manuzzi L.; Maggio I.; Campana D., Should we lose hope in adjuvant therapy for neuroendocrine tumors?—In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit, «JOURNAL OF SURGICAL ONCOLOGY», 2020, 122, pp. 570 - 571 [replica/breve intervento]
Lamberti G.; Andrini E.; Sisi M.; Di Federico A.; Ricciuti B., Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: Rationale and clinical implication, «FUTURE ONCOLOGY», 2020, 16, pp. 1751 - 1766 [articolo]
Maggio I.; Mollica V.; Brighi N.; Lamberti G.; Manuzzi L.; Ricci A.D.; Campana D., The functioning side of the pancreas: a review on insulinomas, «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2020, 43, pp. 139 - 148 [articolo]
Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomino F., The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?, «CANCERS», 2020, 12, Article number: 3129, pp. 1 - 21 [articolo]Open Access
De Giglio A.; Lamberti G.; Facchinetti F.; Genova C.; Andrini E.; Dal Bello M.G.; Tiseo M.; Metro G.; Chiari R.; Ricciuti B., Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib, «CLINICAL LUNG CANCER», 2020, 21, pp. 478 - 487 [articolo]
Ricciuti B.; Lamberti G.; Roila F.; Metro G., Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option, «TRANSLATIONAL LUNG CANCER RESEARCH», 2019, 8, pp. S378 - S382 [articolo]
Francesco Gelsomino,Giancarlo Facchini, Maria Aurelia Barbera,
Giuseppe Lamberti, Stefano Brocchi, Giuseppe Rossi,
Andrea Ardizzoni, Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2019, 14, pp. 141 - 143 [articolo]
